Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy

doi:10.12998/wjcc.v12.i9.1585

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (776)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

HTML

564

Figures (1-3)

Tables (1-2)

Sum=710

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=33

Mar 26, 2024 (publication date) through May 13, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Clin Cases. Mar 26, 2024; 12(9): 1585-1596
Published online Mar 26, 2024. doi: 10.12998/wjcc.v12.i9.1585

Full Size Figure Download Figure

Figure 3 Change observed in the pre-test and post-test averages. A: Change observed in the pre-test and post-test averages of the patients' Wee functional independence measure motor score and cognitive score values; B: Change observed in the pre-test and post-test averages of the patients' Gross motor function classification system and manual ability classification system values. WeeFIM: Wee functional independence measure motor; GMF-CS: Gross motor function classification system; MA-CS: Manual ability classification system.

Citation: Boyalı O, Kabatas S, Civelek E, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy. World J Clin Cases 2024; 12(9): 1585-1596
URL: https://www.wjgnet.com/2307-8960/full/v12/i9/1585.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i9.1585